Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$11.13 - $15.78 $926,216 - $1.31 Million
83,218 New
83,218 $1.24 Million
Q2 2023

Aug 11, 2023

BUY
$40.29 - $82.51 $291,659 - $597,289
7,239 New
7,239 $300,000
Q1 2022

May 13, 2022

SELL
$60.15 - $84.52 $234,945 - $330,135
-3,906 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$75.08 - $121.99 $293,262 - $476,492
3,906 New
3,906 $293,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.37B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Ontario Teachers Pension Plan Board Portfolio

Follow Ontario Teachers Pension Plan Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

News

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.